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Abstract
Background: MicroRNAs (miRNAs) play critical roles in a wide spectrum of biological processes
and have been shown to be important effectors in the intricate host-pathogen interaction
networks. Avian influenza virus (AIV) not only causes significant economic losses in poultry
production, but also is of great concern to human health. The objective of this study was to identify
miRNAs associated with AIV infections in chickens.
Results: Total RNAs were isolated from lung and trachea of low pathogenic H5N3 infected and
non-infected SPF chickens at 4 days post-infection. A total of 278,398 and 340,726 reads were
obtained from lung and trachea, respectively. And 377 miRNAs were detected in lungs and 149 in
tracheae from a total of 474 distinct chicken miRNAs available at the miRBase, respectively.
Seventy-three and thirty-six miRNAs were differentially expressed between infected and non-
infected chickens in lungs and tracheae, respectively. There were more miRNAs highly expressed
in non-infected tissues than in infected tissues. Interestingly, some of these differentially expressed
miRNAs, including miR-146, have been previously reported to be associated with immune-related
signal pathways in mammals.
Conclusion: To our knowledge, this is the first study on miRNA gene expression in AIV infected
chickens using a deep sequencing approach. During AIV infection, many host miRNAs were
differentially regulated, supporting the hypothesis that certain miRNAs might be essential in the
host-pathogen interactions. Elucidation of the mechanism of these miRNAs on the regulation of
host-AIV interaction will lead to the development of new control strategies to prevent or treat AIV
infections in poultry.
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Avian influenza virus (AIV) is a type A virus of the family
Orthomyxovirida. Although wild aquatic birds such as
water fowls and sea gulls are their natural reservoir [1],
land-based birds including chickens may also be infected,
which cause significant economic losses to the poultry
industry, and raise a great public health threat due to
potential host jump from animals to humans [2].
miRNAs are non-coding, single-stranded RNAs of 19~23
nucleotides which represent a novel class of gene regula-
tors and play important roles in a variety of biological
processes in both plants and animals [3-5]. miRNAs mod-
ulate gene expression largely at the post-transcriptional
level by different mechanisms including direct cleavage of
targeted mRNAs [4], inhibition of translation [6] or even
up-regulation of translation [7]. miRNAs are involved in
different biological activities such as development, differ-
entiation, growth and metabolism [8-11]. Recently, in
mammals, miRNAs have been reported to participate in
the regulation of immunity, including development and
differentiation of lymphocytes, monocytes and neu-
trophils, and modulation of inflammation [11]. MiR-150
expresses in mature B and T cells derived from mouse
hematopoietic stem cells, and is able to block early B cell
development when expressed prematurely [12]. MiR-
181a is an intrinsic modulator of T cell sensitivity and
selection in mice [13]. After exposure of THP-1 (human
acute monocytic leukemia cell line) cells to lipopolysac-
charides (LPS), miR-146 was identified as an inhibitor of
signalling proteins of the innate immune responses by
NF-kappaB [14]. miRNAs have also been found to be crit-
ical effectors in the regulation of viral pathogenesis. Two
human encoded miRNAs (miR-136 and miR-507), have
been shown to have potential binding sites for the genes
that code for the polymerase basic 2 (PB2) and hemmag-
glutinin (HA) proteins and are reported to be involved in
the pathogenesis of H5N1 AIV [15]. All of these evidences
suggest that certain miRNAs might be important in the
modulation of AIV infections in chickens.
In order to effectively control AIV infection in poultry, it is
essential to elucidate the mechanisms of virus pathogene-
sis in chickens. However, how host cells interact with AIVs
during infection in poultry remains poorly understood.
Identification of differentially expressed miRNAs in AIV
infected chickens will pave a novel avenue to understand
host-virus interaction. With the development of next gen-
eration sequencing, massively parallel sequencing holds
great promise for expression profiling [16] and it can pro-
vide a superior sensitivity at high sequencing depth to dis-
cover especially those miRNAs with low abundance and
novel miRNAs that are not able to be identified using tra-
ditional cloning approaches. Deep sequencing has been
previously used to profile both chicken miRNAs and
Marek's disease virus miRNAs [17,18]. In the current
study, a Solexa Sequencer was used to deep sequence dif-
ferentially regulated chicken miRNAs in H5N3 infected
and non-infected SPF chickens. Our results will expand
the list of miRNAs which might be related to the host
immune responses in animals.
Results
Virus titration
Virus replication was examined by real-time RT-PCR for
influenza matrix gene from total RNAs of lung and tra-
cheae at 4 dpi. The titer of infected samples was 12.29
log10 EID50/ml in lung, and 3.89 log10 EID50/ml in tra-
cheae. Both non-infected lung and tracheae samples were
negative.
Small RNA libraries
A total of 278,398 and 340,726 filtered high quality reads
were obtained from chicken lungs and tracheae, respec-
tively (Table 1). In the libraries of chicken lungs, 98,849
and 179,549 reads were obtained from infected and non-
infected lungs, respectively. Out of these reads, 52,363 of
these high quality reads were exact matches while another
9,357 reads were loose matches to known chicken miR-
NAs. All reads with a perfect match to mature miRNA
sequences from chicken deposited in miRBase http://
microrna.sanger.ac.uk/ with insertions or deletions of 1-4
nucleotides was considered as a loose match to represent
dicer-processing products from each of the chicken
miRNA precursors. An example from gga-mir-181a is
shown in Figure 1. Here we saw that the sample had 77
copies of a sequence that was identical to that of the
mature gga-mir-181a (denoted by a '*'). In addition we
observed significant alternate processing at the 3'-end that
was characteristic of miRNAs in various copy numbers.
Loose matches were defined by sequence reads that
aligned with chicken miRNA consensus sequence with 1-
4 mismatches. These may represent sequencing errors
(when occurring in low copy numbers), mutations and/or
Table 1: Number of reads of miRNAs from AIV infected and non-infected chicken lungs and tracheae
Infected lungs Non-infected lungs Infected tracheae Non-infected tracheae
High quality/both adapter 98,849 179,549 250,460 90,266
Exact match to known chicken miRNAs 10,939 41,424 36,405 7,838
Loose match to known chicken miRNAs 1,441 7,916 2,926 1,252Page 2 of 20
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Reads aligning with of gga-mir-181aFigure 1
Reads aligning with of gga-mir-181a. Sequence of gga-mir-181a hairpin is described in the top line. The brackets below 
denote the secondary structure. Reads aligning with the mature gga-mir-181a sequence as found in miRBase is denoted by a '*' 
sequence. The +/- 4 nt matches representing reads that perfectly matched the gga-mir-181a precursor with insertions or dele-
tion of 1-4 nucleotides from the 5' and 3' ends are shown below the mature miRNA exact matches. The number of reads cor-
responding to each sequence is shown at the right hand end of the dotted line.
Distributions of reads from each groupFigure 2
Distributions of reads from each group. Notes: All the reads in each group have been transformed by Log10.
BMC Genomics 2009, 10:512 http://www.biomedcentral.com/1471-2164/10/512RNA editing events. In the libraries of chicken trachea,
250,460 reads were obtained from infected tracheae and
90,266 were obtained from non-infected tracheae. Out of
these reads, 44,243 of these high quality reads were exact
matches and another 4,178 reads were loose matches to
known chicken miRNAs. The sum of exact and loose
match reads was used as the total number of reads for each
miRNA.
To display the distribution of miRNAs at each library,
reads of individual miRNA within each group were trans-
formed to log10. The plots of distributions of transformed
reads for each miRNA from each group are shown in Fig-
ure 2. Most miRNAs had around 10-100 reads in these
four groups. There was no significant difference in the
medians of the four libraries (P > 0.05) indicating they
had similar distributions of the miRNA reads.
Of the 474 distinct Gallus gallus (gga) miRNA entries in
miRBase [19-22], 377 miRNAs were identified in chicken
lungs and 149 miRNAs in chicken tracheae. In addition,
we identified 87 potential novel miRNA sequences [see
Additional file 1]. Seven novel miRNAs were selected and
all of them were confirmed by Real-time quantification
PCR in chicken lungs and tracheae, respectively, which is
shown in Table 2.
miRNAs expression profiling analysis
In the present study there were four different groups: two
tissues (lung and trachea) and two states per tissue
(infected and non-infected states). Two comparisons were
made between infected vs. non-infected within tissue and
another two comparisons between lung and trachea at
either infected or non-infected state. Differentially
expressed miRNAs in each comparison were identified (P
< 0.05, Q < 0.05 and fold change > 2). Within tissues, 73
and 36 miRNAs were differentially expressed between
infected and non-infected groups in lungs and tracheae,
respectively (Tables 3, 4). When between tissues were
compared, 57 and 78 miRNAs were differentially
expressed at infected and non-infected states, respectively
(Tables 5, 6).
More miRNAs (60 out of 73 miRNAs in lungs and 27 out
of 36 miRNAs in tracheae) were down-regulated than up-
regulated with AIV infection in both lungs and tracheae.
When infected vs. non-infected was compared, 5 miRNAs
(miR-106, miR-1729, miR-1798, miR-429 and miR-
1711) were only expressed in the non-infected lungs,
while 2 miRNAs (miR-1576 and miR-1636) were only
expressed in infected lungs (Table 3). Between infected
and non-infected tracheae, two (miR-1612 and miR-
1458) out of 27 down-regulated miRNAs were expressed
only in non-infected tracheae (Table 4).
In the comparisons between tissues, only few miRNAs (6
out of 57 miRNAs in the infected state and 1 out of 78
miRNAs in the non-infected state) were highly expressed
in tracheae compared to lungs (Tables 5, 6). Under the
infected state, 28 miRNAs were specifically expressed in
lungs and 23 miRNAs were expressed at higher levels in
lungs than in tracheae. In the non-infected state, 11 miR-
NAs specifically expressed in lungs and 66 miRNAs were
expressed at higher levels in lungs than tracheae. Of par-
ticular interest, miR-1a, miR-140, and miR-449, which
were highly expressed in infected tracheas than the non-
infected ones, and also were differentially expressed
between infected tissues (higher expression levels in
infected tracheae than infected lungs). In the tissue com-
parison under the non-infected state, miR-206 was the
only miRNA that had higher expression level in tracheae
than in lungs. In general, those highly abundant miRNAs
were observed across all four groups examined (Table 7).
Confirmation of differentially expressed miRNAs
TaqMan miRNA assays were used to confirm the expres-
sion pattern of differentially expressed miRNAs in lungs.
There were general consistency between TaqMan assay
and deep sequence analysis in three miRNAs (miR-1a,
miR-125b and miR-146a) in terms of directions of regula-
tion and significance. Specifically, there was a 1.16 fold
up-regulation (2.12 fold in deep sequencing analysis) in
miR-1a, 2.13 fold down-regulation (8.33 fold in deep
sequencing analysis) in miR-125b, and 3.03 fold down-
regulation (3.45 fold in deep sequencing analysis) in miR-
146a (P < 0.05).
Table 2: Expression levels1 of novel miRNAs in chicken lungs and tracheae.
Infected lungs Non-infected lungs Infected tracheae Non-infected tracheae
C1N1 312,681.30 127,134.80 83,221.38 260,694.40
C1N2 8,248,307.00 850,528.50 275,049.80 173,791.70
C1N3 7,546,275.00 966,448.50 726,699.80 3707461.00
C1N4 0.88 0.95 0.67 2.84
C1N5 395.08 263.26 58.67 329.24
C1N6 2,834.08 2,191.45 2,543.03 14,542.62
C1N7 121.38 31.89 172.25 1,088.66
Note: 1 Expression levels were measured in terms of threshold cycle value (CT) and normalized to U6 using 2-ΔΔCT.Page 4 of 20
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miRNA Position on chromosomes Reads in infected Reads in non-infected Ratio infected/non
-infected (Normalized)
gga-mir-1576 chr13:18532632-18532726 8 0 -1
gga-mir-1636 chr 15: 4729959-4730046 6 0 -
gga-mir-206 chr3: 110390439-110390514 101 9 20.38
gga-mir-1793 chr9: 25115521-25115617 25 5 8.36
gga-mir-1599 chr7: 25926968-25927029 48 13 6.71
gga-mir-1701 chr4: 82234261-82234337 27 9 5.45
gga-mir-449 chrZ: 16040613-16040698 38 14 4.93
gga-miR-140 chr11: 21030641-21030735 1438 803 3.25
gga-mir-1416 chrZ: 34596479-34596567 17 10 3.09
gga-mir-1458 chr9: 11743528-11743637 25 15 3.03
gga-mir-1612 chr9: 6031748-6031831 39 31 2.29
gga-mir-1a-1 chr20: 8107831- 8107901 551 471 2.12
gga-mir-1a-2 chr2: 105673483- 105673567 593 523 2.06
gga-mir-103-2 chr4: 91906889-91906971 49 148 0.49
gga-mir-99a chr1: 102424333-102424413 23 92 0.45
gga-mir-456 chr3: 32679710-32679821 30 122 0.45
gga-let-7c chr1: 102425086-102425169 735 3059 0.44
gga-mir-181b-2 chr17: 10220137- 10220221 20 89 0.41
gga-let-7j chr26: 1442697-1442779 648 2938 0.40
gga-mir-15b chr9: 23742966- 23743056 9 41 0.40
gga-let-7a-1 chr12: 6302911-6303000 658 3020 0.40
gga-let-7a-2 chr24: 3380993-3381064 671 3113 0.39
gga-let-7g chr12: 2809078-2809160 342 1623 0.38
gga-mir-181a-2 chr17: 10218497-10218587 57 283 0.37
gga-mir-200b chr21: 2585642-2585726 14 72 0.35
gga-let-7a-3 chr1: 73421272-73421347 892 4699 0.34
gga-mir-100 chr21: 3372894-3372973 15 79 0.34
gga-mir-30d chr2: 148337263-148337326 60 334 0.33
gga-mir-30e chr23: 5248414-5248509 20 112 0.32
gga-mir-181a-1 chr8: 2001561-2001664 65 366 0.32
gga-mir-181b-1 chr8: 2001750-2001838 18 106 0.31
gga-let-7k chr26: 1442897-1442979 53 327 0.29
gga-mir-125b chr1: 102457647-102457736 19 119 0.29
gga-mir-1b chr23: 4663912-4663975 10 63 0.29
gga-mir-146b chr6: 24570060-24570164 102 691 0.27
gga-mir-10a chrun_random: 379304-379377 86 598 0.26
gga-mir-101-2 chr8: 29051918-29051993 18 136 0.24
gga-mir-27b chrZ: 41157642-41157738 5 41 0.22
gga-mir-144 chr19: 5824123-5824207 11 94 0.21
gga-let-7f chr12: 6302497-6302583 947 8228 0.21
gga-mir-33-1 chr1: 51372282-51372350 2 19 0.19
gga-mir-126 chr17: 8431742-8431825 25 250 0.18
gga-mir-1456 chrZ: 44167486-44167595 2 20 0.18
gga-mir-22 chr19: 5352096- 5352195 4 43 0.17
gga-mir-16c chr4: 4048689- 4048759 6 65 0.17
gga-mir-30a-3p chr3: 85102239- 85102310 58 656 0.16
gga-mir-101 chrZ: 28037874- 28037952 19 219 0.16
gga-mir-30a-5p chr3: 85102239- 85102310 68 785 0.16
gga-mir-30c-1 chr23: 5249637-5249725 3 37 0.15
gga-mir-146c chr4: 92169271- 92169399 18 243 0.13
gga-mir-26a chr2: 4467516- 4467592 98 1326 0.13
gga-mir-451 chr19: 5823968-5824036 93 1287 0.13
gga-mir-146a chr13: 7555593- 7555691 7 105 0.12
gga-mir-21 chr19: 7322072-7322168 46 771 0.11
gga-mir-24 chrZ: 41158175-41158242 18 344 0.10
gga-mir-17-3p chr1: 152248781-152248865 2 44 0.08
gga-mir-20a chr1: 152248306-152248403 1 23 0.08
gga-mir-23b chrZ: 41157406-41157491 12 285 0.08
gga-mir-142-3p chr19: 496983-497070 2 49 0.07Page 5 of 20
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Chromosomal positions of differentially expressed miR-
NAs revealed that some of them were very close to each
other. According to a previous report [23], miRNAs can be
grouped as one cluster if they are less than 1,000 bp apart
on the same chromosome. Based on the miRBase 13.0
[19-22], there are 20 miRNA clusters in the chicken
genome according to the criteria above. Eighteen of these
clusters were detected in lungs and 12 clusters in tracheae,
respectively (Table 8). Each cluster contained at least two
miRNAs, and total of 47 miRNAs were included in these
clusters. Within these clusters, the mir-92-mir-19b-mir-
20a-mir-19a-mir-18a-mir-17, which is equivalent to the
mammalian mir-17-92 cluster, and mir-302b-mir-302c-
mir-1811-mir-302a-mir-302d-mir-367 cluster were the
biggest clusters containing six miRNAs. Both of them were
detected in lungs. There were only seven clusters differen-
tially expressed (all miRNAs within the cluster differen-
tially expressed in the comparison of infection vs. non-
infection or between tissues). Clusters mir-16-1-mir-15a,
let-7f-let-7a-1, mir-181a-1-mir-181b-1, let-7j-let-7k, mir-
23b-mir-27b-mir-24, and mir-16-2-mir-15b were down-
regulated in lungs and mir-181a-1-mir-181b-1 was also
down-regulated in tracheae with AIV infection. Cluster
mir-34b-mir-34c was up-regulated in tracheae.
Gene ontology analysis
Potential target genes of differentially expressed miRNAs
in each comparison were predicted by miRanda [24]. In
brief, each differentially expressed miRNA was submitted
to miRanda individually and all of its targets predicted in
miRanda were used for the following gene ontology (GO)
analysis. For each comparison, target genes of induced
and repressed miRNAs were separately analyzed. All tar-
gets of induced miRNAs in each comparison were submit-
ted to DAVID program [25] and so were the targets of
repressed miRNAs. Functional category enrichment based
on the GO terms was evaluated on the targets of these dif-
ferentially expressed miRNAs. All enriched GO terms in
biological process of each comparison were shown in
Additional file 2. Immune related GO terms of each com-
parison are presented in Figures 3, 4, 5 and 6.
In the comparison of infected vs. non-infected lungs, 15
immune related GO terms in biological process were sig-
nificantly enriched (P < 0.05) (Figure 3) from the targets
of down-regulated miRNAs. Response to virus was the GO
term with the highest fold enrichment (15 folds). Other
functional terms including immune system response,
lymphocytes, and lung development were also identified.
In the comparison of infected vs. non-infected tracheae,
six immune-related GO terms in biological process were
significantly enriched (P < 0.05) (Figure 4) from the tar-
gets of down-regulated miRNAs, in which interleukin-12
production and interleukin-12 biosynthetic process had
the highest fold enrichment (9.8 folds). For the targets of
up-regulated miRNAs between the infected vs. non-
infected both in lung and trachea comparisons, only two
immune related GO terms: immunoglobulin I set and
immunoglobulin subtype 2 in INTERPRO category were
significantly enriched.
For the tissue comparison under the infected state, targets
of induced miRNAs in lungs were associated with ten
immune related GO terms in biological process including
tissue development, interleukin-12, lymphocytes
cytokines and immune system development (P < 0.05)
(Figure 5). Targets of repressed miRNAs in lungs were
associated with immune system development and immu-
noglobulin subtype 2 in the INTERPRO category. Under
the non-infected state, 15 immune related terms were sig-
nificantly enriched in biological process in the targets of
miRNAs highly expressed in lungs. These GO terms were
related to lung development and host immune system
(Figure 6). The GO term NF-kappaB binding was also
enriched in molecular function (P < 0.05).
gga-mir-142-5p chr19: 496983-497070 2 49 0.07
gga-mir-17-5p chr1: 152248781-152248865 2 55 0.07
gga-mir-19b chr1: 152248183-152248269 1 31 0.06
gga-mir-30c-2 chr3: 85126853-85126924 1 34 0.05
gga-mir-739 7 241 0.05
gga-mir-15c chr4: 4049055-4049130 1 46 0.04
gga-mir-15a chr1: 173700493-173700575 2 102 0.04
gga-mir-16-2 chr9: 23742791-23742884 1 67 0.03
gga-mir-16-1 chr1: 173700351-173700434 1 107 0.02
gga-mir-106 chr4: 3970359-3970439 0 27 +2
gga-mir-1729 chr15: 769596-769666 0 24 +
gga-mir-1798 chr20: 9654914-9655009 0 24 +
gga-mir-429 chr21: 2580812-2580895 0 22 +
gga-mir-1711 chr12: 17010140-17010207 0 18 +
Note: 1 Specifically expressed in infected lungs.
2 Specifically expressed in non-infected lungs.
Table 3: Differentially expressed miRNAs between infected and non-infected lungs (P < 0.05, Q < 0.05 and Ratio > 2) (Continued)Page 6 of 20
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The impact of miRNAs expression on the understanding
of molecular mechanisms in gene regulations has been
remarkable. Although thousands of small RNAs have
been identified over the last decade, the challenge remains
to fully identify all small nuclear RNAs, especially very
low abundant ones and to determine their individual
functions. The majority of known miRNAs have been
identified through traditional cloning method, which is
both time consuming and labor intensive. The advantages
of next-generation sequencing technologies have pro-
vided an innovative tool to look into the genome with
unprecedented depth of coverage. Solexa deep sequencing
is one of these high throughput technologies, by which
miRNAs can be detected in any organism without prior
sequence or secondary structure information. This tech-
nology has been used in many species including human,
mice and birds [17,18,26-28]. Expression of miRNAs var-
ies in different developmental stages [29-31]. Chicken
miRNAs identified in the present study provided novel
information in the profiling of miRNAs not only in AIV
infected chickens, but also the two tissues (lung and tra-
chea) that have not been previously examined for miRNA
profiling in chickens. To our knowledge, this is the first
study to profile chicken miRNAs in AIV infected chickens
by deep sequencing approach. There are 474 chicken miR-
NAs predicted in miRBase 13.0 [19-22]. The deep
sequencing results in the current study experimentally
confirmed 377 miRNAs in chicken lungs and 149 miRNAs
in chicken tracheae, and the approach is more powerful
than other conventional technologies previously used in
birds [30]. The identification of these chicken miRNAs
will be very useful in further investigating the functions
and regulatory mechanisms of miRNAs in the chicken.
Table 4: Differentially expressed miRNAs between infected and non-infected tracheae (P < 0.05, Q < 0.05 and Ratio > 2)
miRNA Position on chromosomes Reads in infected Reads in non-infected Ratio infected/non-infected (Normalized)
gga-mir-1a-2 chr2: 105673483- 10567356 11423 441 9.34
gga-mir-1a-1 chr20: 8107831- 8107901 10438 405 9.29
gga-mir-455-3p chr17:6021890-6021975 29 2 5.23
gga-mir-455-5p chr17:6021890-6021975 29 2 5.23
gga-mir-34b chr24: 5684900-5684983 870 82 3.82
gga-mir-499 chr20: 2599334-2599424 154 15 3.70
gga-mir-34c chr24: 5685637-5685710 540 64 3.04
gga-mir-140 chr11: 21030641-21030735 2334 383 2.20
gga-mir-1b chr23: 4663912-4663975 66 11 2.16
gga-mir-456 chr3: 32679710-32679821 37 28 0.48
gga-mir-125b chr1: 102457647-102457736 31 24 0.47
gga-mir-148a chr2: 32053543-32053610 116 94 0.44
gga-let-7b chr1: 73422101-73422185 1761 1460 0.43
gga-mir-181a-1 chr8: 2001561-2001664 59 49 0.43
gga-mir-146c chr4: 92169271- 92169399 42 36 0.42
gga-mir-181a-2 chr17: 10218497-10218587 51 45 0.41
gga-let-7g chr12: 2809078-2809160 413 373 0.40
gga-mir-206 chr3: 110390439-110390514 95 88 0.39
gga-mir-222 chr1: 114216027-114216124;
chr1: 114218422-114218519
14 13 0.39
gga-let-7k chr26: 1442897-1442979 58 54 0.39
gga-mir-181b-2 chr17: 10220137- 10220221 20 21 0.34
gga-let-7i chr1: 34895687-34895770 123 136 0.33
gga-mir-126 chr17: 8431742-8431825 17 19 0.32
gga-mir-99a chr1: 102424333-102424413 14 16 0.32
gga-mir-30a-3p chr3: 85102239- 85102310 66 76 0.31
gga-mir-30a-5p chr3: 85102239- 85102310 74 87 0.31
gga-mir-146b chr6: 24570060-24570164 78 107 0.26
gga-mir-181b-1 chr8: 2001750-2001838 18 25 0.26
gga-mir-30d chr2: 148337263-148337326 46 68 0.24
gga-mir-100 chr21: 3372894-3372973 25 41 0.22
gga-mir-92 chr1: 152248070-152248070 24 40 0.22
gga-mir-15a chr1: 173700493-173700575 3 9 0.12
gga-mir-451 chr19: 5823968-5824036 14 89 0.06
gga-mir-10a chrun_random: 379304-379377 11 139 0.03
gga-mir-1612 chr9: 6031748-6031831 0 9 -1
gga-mir-1458 chr9: 11743528-11743637 0 7 -
Note: 1 Specifically expressed in non-infected tracheae.Page 7 of 20
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Table 5: Differentially expressed miRNAs between infected lungs and tracheae (P < 0.05, Q < 0.05 and Ratio > 2)
miRNA Position on chromosomes Reads in lungs Reads in tracheae Ratio lung/trachea (Normalized)
gga-mir-1599 chr7: 25926968-25927029 48 0 -1
gga-mir-1612 chr9: 6031748-6031831 39 0 -
gga-mir-1701 chr4: 82234261-82234337 27 0 -
gga-mir-1458 chr9: 11743528-11743637 25 0 -
gga-mir-1793 chr9: 25115521-25115617 23 0 -
gga-mir-181b-2 chr17: 10220137- 10220221 20 0 -
gga-mir-1416 chrZ: 34596479-34596567 17 0 -
gga-mir-7-1 chrZ: 8107831-8107901 16 0 -
gga-mir-7b chr1: 73422101-73422185 15 0 -
gga-mir-1638 chr5: 58712377- 58712463 13 0 -
gga-mir-144 chr19: 5824123-5824207 11 0 -
gga-mir-1761 chr8: 17523212-17523292 9 0 -
gga-mir-1576 chr13:18532632-18532726 8 0 -
gga-mir-1814 chr4: 61722590-61722663 8 0 -
gga-mir-1452 chrZ: 8107831-8107901 7 0 -
gga-mir-1815 chr6: 29566734-29566810 7 0 -
gga-mir-122-1 chrZ: 649337-649413 6 0 -
gga-mir-122-2 chrurn_random: 12066796-12066872 6 0 -
gga-mir-1636 chr15: 4729959-4730046 6 0 -
gga-mir-1659 chr7: 14764187-14764287 6 0 -
gga-mir-1786 chr14: 7801714-7801822 6 0 -
gga-mir-218-1 chr4: 77774698-77774806 5 0 -
gga-mir-218-3 5 0 -
gga-mir-7-2 chr10: 14823525-14823623 5 0 -
gga-mir-1467 chr2: 141373919-141374028 4 0 -
gga-mir-1630 chr9: 1883593-1883649 4 0 -
gga-mir-1816 chr2: 90603851-90603955 4 0 -
gga-mir-7-3 chr28: 4436025-4436119 4 0 -
gga-mir-10a chrun_random: 379304-379377 86 11 19.81
gga-mir-451 chr19: 5823968-5824036 93 14 16.83
gga-mir-184 chr10: 22146245-22146318 11 3 9.29
gga-mir-193b chr14: 759453-759535 11 3 9.29
gga-mir-181a-2 chr17: 10218497-10218587 57 18 8.02
gga-mir-205a chr26: 2896047-2896142 6 2 7.60
gga-mir-92 chr1: 152248070-152248070 42 24 4.43
gga-mir-99a chr1: 102424333-102424413 23 14 4.16
gga-mir-126 chr17: 8431742-8431825 25 17 3.73
gga-let-7i chr1: 34895687-34895770 177 123 3.65
gga-mir-146b chr6: 24570060-24570164 102 78 3.31
gga-mir-30d chr2: 148337263-148337326 60 46 3.30
gga-mir-181a-1 chr8: 2001561-2001664 65 51 3.23
gga-let-7b chr1: 73422101-73422185 2008 1761 2.89
gga-mir-206 chr3: 110390439-110390514 101 95 2.69
gga-mir-148a chr2: 32053543-32053610 114 116 2.49
gga-mir-30a-5p chr3: 85102239- 85102310 68 74 2.33
gga-let-7k chr26: 1442897-1442979 53 58 2.32
gga-mir-30a-3p chr3: 85102239- 85102310 58 66 2.23
gga-mir-30e chr23: 5248414-5248509 20 23 2.20
gga-let-7g chr12: 2809078-2809160 342 413 2.10
gga-mir-456 chr3: 32679710-32679821 30 37 2.05
gga-mir-103-2 chr4: 91906889-91906971 65 82 2.01
gga-mir-1b chr23: 4663912-4663975 10 66 0.38
gga-mir-34b chr24: 5684900-5684983 112 870 0.37
gga-mir-34c chr24: 5685637-5685710 78 540 0.37
gga-mir-499 chr20: 2599334-2599424 13 154 0.21
gga-mir-1a-1 chr20: 8107831- 8107901 551 10438 0.13
gga-mir-1a-2 chr2: 105673483- 10567356 593 11423 0.13
Note: 1 Specifically expressed in infected lungs.
BMC Genomics 2009, 10:512 http://www.biomedcentral.com/1471-2164/10/512Table 6: Differentially expressed miRNAs between non-infected lungs and tracheae (P < 0.05, Q < 0.05 and Ratio > 2)
miRNA Position on chromosomes Reads in lungs Reads in tracheae Ratio lung/trachea (Normalized)
gga-mir-30c-2 chr3: 85126853-85126924 34 0 -1
gga-mir-19b chr1: 152248183-152248269 31 0 -
gga-mir-1798 chr20: 9654914-9655009 24 0 -
gga-mir-1456 chrZ: 44167486-44167595 20 0 -
gga-mir-1711 chr12: 17010140-17010207 18 0 -
gga-mir-122-1 chrZ: 649337-649413 17 0 -
gga-mir-203 chr:5: 53206814-53206911 16 0 -
gga-mir-122-2 chrurn_random: 12066796-12066872 14 0 -
gga-mir-1599 chr7: 25926968-25927029 13 0 -
gga-mir-1638 chr5: 58712377- 58712463 12 0 -
gga-mir-1761 chr8: 17523212-17523292 12 0 -
gga-mir-144 chr19: 5824123-5824207 94 2 23.63
gga-mir-146a chr13: 7555593- 7555691 105 3 17.60
gga-mir-739 241 7 17.31
gga-mir-106 chr4: 3970359-3970439 27 1 13.57
gga-mir-16-1 chr1: 173700351-173700434 107 4 13.45
gga-mir-193a chr18: 6423770-6423846 26 1 13.07
gga-mir-142-3p chr19: 496983-497070 49 2 12.32
gga-mir-142-5p chr19: 496983-497070 49 2 12.32
gga-mir-1729 chr15: 769596-769666 24 1 12.07
gga-mir-20a chr1: 152248306-152248403 23 1 11.56
gga-mir-21 chr19: 7322072-7322168 771 40 9.69
gga-mir-17-5p chr1: 152248781-152248865 55 3 9.22
gga-mir-16-2 chr9: 23742791-23742884 67 4 8.42
gga-mir-24 chrZ: 41158175-41158242 344 21 8.24
gga-mir-30e chr23: 5248414-5248509 112 7 8.04
gga-mir-15c chr4: 4049055-4049130 46 3 7.71
gga-mir-223 chr:4: 232949-233048 15 1 7.54
gga-mir-29a chr1: 3236329-3236417 15 1 7.54
gga-mir-29c chr26: 2511658-2511746 15 1 7.54
gga-mir-17-3p chr1: 152248781-152248865 55 3 7.37
gga-mir-451 chr19: 5823968-5824036 1287 89 7.27
gga-mir-101 chrZ: 28037874- 28037952 219 16 6.88
gga-mir-126 chr17: 8431742-8431825 250 19 6.61
gga-mir-26a chr2: 4467516- 4467592 1326 103 6.47
gga-mir-130c chr19: 7145027-7145120 25 2 6.28
gga-mir-23b chrZ: 41157406-41157491 285 23 6.23
gga-mir-30c-1 chr23: 5249637-5249725 37 3 6.20
gga-mir-193b chr14: 759453-759535 23 2 5.78
gga-mir-101-2 chr8: 29051918-29051993 136 12 5.70
gga-mir-15a chr1: 173700493-173700575 102 9 5.70
gga-let-7f chr12: 6302497-6302583 8228 781 5.30
gga-mir-27b chrZ: 41157642-41157738 41 4 5.15
gga-mir-30a-5p chr3: 85102239- 85102310 785 87 4.54
gga-mir-30a-3p chr3: 85102239- 85102310 656 76 4.34
gga-mir-16c chr4: 4048689- 4048759 65 8 4.08
gga-mir-181a-1 chr8: 2001561-2001664 366 49 3.76
gga-mir-200b chr21: 2585642-2585726 72 10 3.62
gga-mir-22 chr19: 5352096- 5352195 43 6 3.60
gga-let-7a-3 chr1: 73421272-73421347 3193 468 3.43
gga-mir-146c chr4: 92169271- 92169399 243 36 3.39
gga-mir-146b chr6: 24570060-24570164 691 107 3.25
gga-mir-181a-2 chr17: 10218497-10218587 283 45 3.16
gga-let-7k chr26: 1442897-1442979 327 54 3.04
gga-mir-15b chr9: 23742966- 23743056 41 7 2.94
gga-let-7a-2 chr24: 3380993-3381064 3113 540 2.89
gga-mir-99a chr1: 102424333-102424413 92 16 2.89
gga-mir-1b chr23: 4663912-4663975 63 11 2.88
gga-mir-199-1 chr17: 5667150-5667243 541 95 2.86Page 9 of 20
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differential miRNA expression and human diseases
[32,33]. miRNAs can regulate many aspects of the
immune response, including the development and differ-
entiation of B and T cells, proliferation of monocytes and
neutrophils, antibody switching and the release of inflam-
matory mediators by regulating basic component of host
immune system [34-36]. MiR-155 has been reported by
several groups to play important roles in both innate and
adaptive immune responses in mammals [11,37,38].
MiR-155 deficient mice lacked the capability to generate
defensive immune responses and to develop lym-
phocytes, especially B-cell, and antigen-presenting cell
functions [39]. However, miR-155 showed very low abun-
dance in both lungs and tracheae and no significant differ-
ential expression was observed in the present study. Over
expression of miR-181a in mature mouse T cells can aug-
ment the sensitivity to peptide antigens, while suppress-
ing miR-181a expression can reduce sensitivity and impair
both positive and negative selection [13]. Selective expres-
sions of miR-181a in the thymus and miR-223 in the bone
marrow have been shown to be involved in the differenti-
ation of pluripotent hematopoietic stem cells into the var-
ious blood cells lineages including B and T cells [40,41].
In the present study, miR-223 was not significantly regu-
lated while miR-181a was down-regulated in both
infected lungs and tracheae. In addition, miR-181a had a
higher expression level in lungs than in tracheae under
both infected and non-infected states. The expression lev-
els of miR-181a, 181a* and 181b were investigated in LPS
activated and CD40-lignad activated macrophages of
chickens, respectively [42]. Only miR-181b was expressed
in the macrophage cell line HD11 as well in the spleen
adherent cells and that its expression increased after acti-
vation by LPS or CD40-ligand [42]. In the current study,
miR-181b had same expression pattern with miR-181a in
both lung and trachea comparisons. These results suggest
that miR-181a and miR-181b may be strong miRNA can-
didates that regulate host response to AIV infection, and
gga-mir-199-2 chr8: 4732773-4732880 541 95 2.86
gga-let-7a-1 chr12: 6302911-6303000 3020 532 2.85
gga-let-7a-3 chr1: 73421272-73421347 1506 266 2.85
gga-let-7j chr26: 1442697-1442779 2938 522 2.83
gga-mir-221 chr1: 114218926-114219024 129 23 2.82
gga-mir-128-1 chr7: 3222815032228231 43 8 2.70
gga-mir-125b chr1: 102457647-102457736 119 24 2.49
gga-mir-30d chr2: 148337263-148337326 344 68 2.47
gga-mir-103-2 chr4: 91906889-91906971 243 51 2.40
gga-let-7i chr1: 34895687-34895770 633 136 2.34
gga-mir-107 chr6: 20487964-20488044 77 17 2.28
gga-let-7c chr1: 102425086-102425169 3059 679 2.26
gga-mir-456 chr3: 32679710-32679821 122 28 2.19
gga-let-7g chr12: 2809078-2809160 1623 373 2.19
gga-mir-10a chrun_random: 379304-379377 598 139 2.16
gga-mir-181b-1 chr8: 2001750-2001838 106 25 2.13
gga-mir-181b-2 chr17: 10220137- 10220221 89 21 2.13
gga-mir-34b chr24: 5684900-5684983 337 82 2.07
gga-mir-206 chr3: 110390439-110390514 9 88 0.05
Note: 1 Specifically expressed in non-infected lungs.
Table 6: Differentially expressed miRNAs between non-infected lungs and tracheae (P < 0.05, Q < 0.05 and Ratio > 2) (Continued)
Table 7: Highly abundant miRNAs in all four libraries
Name Uninfected lung
(179,549)1
Infected lung
(98,849)
Uninfected trachea
(90,266)
Infected trachea
(250,460)
gga-let-7b 4,732 2,008 1,460 1,761
gga-let-7f 8,228 947 781 1,949
gga-let-7a-3 3,193 562 468 917
gga-let-7c 3,059 735 679 1,327
gga-mir-140 803 1,438 383 2,334
gga-mir-1a-2 523 593 441 11,423
gga-mir-1a-1 471 551 405 10,438
gga-let-7a-2 1,633 341 276 549
gga-let-7g 1,623 342 373 413
gga-let-7a-1 1,510 329 266 532
Note: 1 Total number of reads for each groupPage 10 of 20
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tion mechanism in chickens.
Although the interaction between miRNA expression and
virus infection remains to be elucidated, we speculated
that miRNA might target immune related genes or modu-
late virus replication. Sequencing of chicken miRNAs in
Marek's disease virus (MDV) infected and non-infected
chicken embryo fibroblast (CEF) indicated that more
miRNAs were up-regulated in MDV infected cells [17].
These results differ from the current study in which most
differentially expressed miRNAs (55 out of 73 in lungs
and 27 out of 36 in tracheae) were down-regulated in AIV
infected tissues. These results indicate that the mecha-
nisms of miRNA regulation of the host response to differ-
ent types of virus in chickens are different. Chicken miR-
221 and miR-222, the most abundant miRNAs in the CEF
small RNA libraries, had significantly higher reads in
MDV infected than non-infected CEF [17]. While both
miR-221 and 222 had relatively lower abundance in the
present study. These results demonstrate that miRNA
expression can be tissue-specific with high abundance of
miR-221 and 222 in the CEF libraries and low abun-
dances in lungs and tracheae. It can also be speculated
that host miRNAs expression may be suppressed by AIV
replication based on the miRNA expression patterns
observed in the current study.
Some miRNAs have been shown to be directly involved in
virus replication. A liver specific miRNA (miR-122) was
shown to be required for Hepatitis C virus (HCV) replica-
tion in humans [43]. MiR-122 can positively affect the
viral replication and has become a therapeutic target for
the treatment of HCV infection [44]. In the current study,
miR-122 specifically expressed in chicken lungs compared
to tracheae under both infected and non-infected states.
These data suggest miR-122 might play a more important
role in tissue distribution than the responses to AIV infec-
tion in chickens. Another two human miRNAs (miR-507
and miR-136) have potential target binding sites in
polymerase basic 2 (PB2) and hemagglutinin (HA) genes
of AIV, respectively [15]. Unfortunately, these two miR-
NAs are absent in the chicken genome, which might indi-
cate different infectivity and lethality of the virus between
chickens and humans.
Although in the present study most differentially
expressed miRNA were down-regulated during AIV infec-
tion, some miRNAs were also up-regulated. MiR-1a, miR-
140 and miR-449 were significantly up-regulated in both
tissues, while miR-455, miR-34b and miR-34c were only
up-regulated with AIV infection in tracheae. This suggests
different miRNA regulation mechanisms might exist on
host response to virus infection. These up-regulated miR-
NAs might inhibit gene expression of their target genes;
Table 8: Identified miRNA clusters
Cluster Chromosome locations Expressed in lungs Expressed in tracheae
let-7a-3-let-7b Chr1: 73421272-73421347; 73422101- 73422185 Y1 Y
mir-222-mir-221 Chr1: 114218422- 114218519; 11421 8926-114219024 Y Y
mir-92-mir-19b-mir-20a-mir-19a-mir-
18a-mir-17
Chr1: 152248070-152248147; 152248 183-152248269; 
152248306- 1522484 03; 152248492 -152248572; 
1522486 26-152248718; 152248781-152248865
Y N2
mir-16-1-mir-15a Chr1: 173700351-173700434; 173700 493-173700575 Y Y
mir-20b-mir-18b Chr4: 3970047-3970131; 3970228-
3970311
Y N
mir-302b-mir-302c-mir-1811-mir-
302a-mir-302d-mir-367
Chr4: 58651314-58651385; 58651576- 58651640; 
58651698-58651778; 5865 1879-58651945; 58652214-
58652282; 58652350-58652422
Y N
mir-1547-mir-204-2 Chr10: 6651001-6651074; 6651274- 6651374 Y N
mir-1720-mir-7-2 Chr10: 14823390-14823454; 14823525 -14823623 Y Y
let-7f-let-7a-1 Chr12: 6302497-6302583; 6302911- 6303000 Y Y
mir-1763-mir-1564 Chr14: 12895655-12895720; 12896507-12896577 Y N
mir-34b-mir-34c Chr24: 5684900-5684983; 5685637- 5685710 Y Y
let-7j-let-7k Chr26: 1442697-1442779; 1442897- 1442979 Y Y
mir-29c-mir-29b-2 Chr26: 2511658-2511746; 2512569- 2512648 Y N
mir-181a-1-mir-181b-1 Chr8: 2001561-2001664; 2001750- 2001838 Y Y
mir-1b-mir-133c Chr23: 4663912-4663975; 4664051- 4664129 N Y
mir-449-mir-449b ChrZ: 16040613-16040698; 16040763 -16040856 Y Y
mir-216b-mir-1461 Chr3: 288214-288302; 288216-288301 N N
mir-23b-mir-27b-mir-24 ChrZ: 41157406-41157491; 41157642- 41157738; 
41158175-41158242
Y Y
mir-194-mir-215 Chr3: 19924487-19924561; 19924793 -19924897 Y N
mir-16-2-mir-15b Chr9: 23742791-23742884; 23742966 -23743056 Y Y
Note: 1 Identified in the library
2 Not identified in the libraryPage 11 of 20
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help the host to inhibit virus replication.
Different tissues serve different biological functions in
animals and the expression patterns of miRNAs can vary
in different tissues [23,30]. miRNAs in bursa and spleen
of developing chicken embryo have been recently identi-
fied, and diverse expression patterns of these miRNAs
between different immune organs were observed, suggest-
ing that miRNAs may function as dynamic regulators of
the vertebrate immune system [45]. Some miRNAs show
tissue-specific distribution in mouse, suggesting specific
functions within these tissues [46]. In the current study,
chicken lung and trachea were examined, as they are both
part of the respiratory system and important sites for AIV
replication. There was a significant difference in miRNA
expression between lung and trachea with more miRNAs
expressed in lungs (377 miRNAs identified) than tracheae
(149 miRNAs identified), although only small percentage
of miRNAs (19% in lung and 24% in trachea) were signif-
icantly differentially expressed in AIV infected samples.
When tissues in the state of virus infection were com-
pared, 28 and 23 miRNAs were specifically and highly
expressed in lungs, respectively, and only 6 miRNAs (miR-
1a-1 and 2, miR-1b, miR-34b, 34c and miR-449) were
highly expressed in tracheae (Table 5). When tissues were
compared under the non-infected state, all differentially
expressed miRNAs were expressed at higher levels in lungs
than tracheae with the only exception of miR-206, which
showed a higher expression level in non-infected trachea
than lung (Table 6). More interestingly, miR-206 was up-
regulated in virus infected vs. non-infected lungs and was
down-regulated in infected vs. non-infected tracheae. We
can conclude that miR-206 has an opposite regulatory
role in lungs and tracheae or might have different targets
in different tissues and therefore play different roles in
host-virus interactions. MiR-1458 and miR-1612 were up-
Enriched immune related GO terms of target genes of repressed differentially expressed miRNAs in the comparison of infected vs. non-infected lungsFigur  3
Enriched immune related GO terms of target genes of repressed differentially expressed miRNAs in the com-
parison of infected vs. non-infected lungs. Notes: Fold enrichment is a ratio obtained by dividing user's percentage by the 
percentage of each category of the whole genome.
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BMC Genomics 2009, 10:512 http://www.biomedcentral.com/1471-2164/10/512regulated in AIV infected chicken lungs, while they were
specifically expressed in non-infected tracheae not the
infected one (Tables 3 and 4). The different regulation of
miR-1458 and miR-1612 between lung and trachea sug-
gests they may also have different mechanisms in
response to AIV infection between tissues.
We hypothesize that miR-34b, miR-34c, miR-206, miR-
1458 and miR-1612 might be some of the most important
miRNAs associated with AIV infection. Significantly dif-
ferent miRNA expression pattern between lung and tra-
chea suggests the regulatory mechanism of miRNAs on
host response to the AIV infection between lung and tra-
chea is distinct. However, similar regulatory mechanism
might also exist in these two tissues. Within the down-reg-
ulated miRNAs in infected vs. non-infected lungs and tra-
cheae, there were 18 miRNAs which overlapped in both
tissues. This suggests that these 18 miRNAs might have
common modulation mechanisms with the AIV infection
in chickens.
GO term enrichment analysis has been widely used in
functional analysis and allows the identification of impor-
tant categories associated with functions of interests. GO
terms enriched by the target genes of differentially
expressed miRNAs in the current study can provide useful
information for the follow-up study to elucidate the regu-
latory mechanism of miRNAs in host immune response to
AIV infection. During AIV infection, the host immune sys-
tem is stimulated to develop a defensive mechanism,
which might be the reason why genes involved in
immune system development were enriched in all com-
parisons.
With virus infection, more immune related GO terms
were enriched by the targets of repressed miRNAs in lungs
than in tracheae (15 terms in lung comparison and 6
terms in trachea comparison) (Figures 3 and 4). Response
to virus was identified as the most enriched term (15 fold
enrichment) in lung comparison, confirming that genes
related to virus infection were regulated by miRNAs. The
hyperinduction of proinflammatory cytokines such as
TNF-α and IFN-β in human macrophages and respiratory
epithelial cells by the highly pathogenic AIV H5N1 was
believed to contribute to its high pathogenecity [47]. Lym-
phocytes were also reported to be suppressed by AIV [48].
Enrichments of T-cell and leukocytes activation and
cytokines activities terms identified in the comparison of
Enriched immune related GO terms of target genes of repressed differentially expressed miRNAs in comparison of infected vs. non-infected tracheaeFigur  4
Enriched immune related GO terms of target genes of repressed differentially expressed miRNAs in compari-
son of infected vs. non-infected tracheae. Notes: Fold enrichment is a ratio obtained by dividing user's percentage by the 
percentage of each category of the whole genome.
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host immune system response against virus infection.
Meanwhile, GO terms involved in lung development and
epithelium morphogenesis were enriched, suggesting the
genes associated with lung epithelium development in
lungs may be important for the recovery from AIV infec-
tion in chickens.
It was interesting that two GO terms, interleuklin-12 pro-
duction and biosynthetic process, were enriched in the
infected tissue comparison, which were not included in
the non-infected comparison. These two terms were also
enriched in the comparison of infected vs. non-infected
trachea instead of the lung comparison. IL-12 plays a piv-
otal regulatory role in the anti-viral response due to its
induction of IFN-γ, an anti-viral cytokine [49]. These may
suggest that a different defensive mechanism against virus
infection might occur in trachea compared to lungs.
The two terms, response to virus and T-cell activation were
also enriched by immune related genes differentially
expressed in the early immune responses to H9N2 infec-
tion in tracheal organ cultures (TOC) [50]. Host immune
response, showed as adaptive immune responses in the
current study, was enriched by differentially expressed
genes in H5N1 infected chicken embryo fibroblasts (CEF)
as well [51]. Influenza virus triggered a cascade of both
innate and specific immune responses. Then both
immune related genes and miRNAs who might regulate
these genes maybe involved in similar biological proc-
esses with the same GO terms.
Of special note, NF-KappaB binding was also enriched in
the comparison between lung and trachea under non-
infected state. A similar GO term, regulation of NF-Kap-
paB, was enriched in the previous TOC model with the
infection of AIV H9N2 [50]. Activation of NF-KappaB
pathway is an essential immediate early step of immune
activation. Many viruses have developed strategies to
manipulate NF-KappaB signalling through the use of mul-
tifunctional viral proteins that target the host innate
immune response pathways [52]. Enrichment of GO term
NF-KappaB binding suggests these two tissues might uti-
lize this signal pathway differently.
Post-transcriptional gene activity can be regulated
through the interaction of regulatory RNA-binding pro-
teins and small non-coding RNAs such as miRNAs [4,53].
Enriched immune related GO terms of target genes of induced differentially expressed miRNAs in comparison of infected lungs a d tracheaeFigu  5
Enriched immune related GO terms of target genes of induced differentially expressed miRNAs in comparison 
of infected lungs and tracheae. Notes: Fold enrichment is a ratio obtained by dividing user's percentage by the percentage 
of each category of the whole genome.
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BMC Genomics 2009, 10:512 http://www.biomedcentral.com/1471-2164/10/512miRNAs can modulate protein activities by altering
mRNA stability, translational efficiency or localization
[53,54]. The 3' untranslated regions (3' UTR) are widely
accepted as important post-transcriptional regulatory
regions of mRNAs, which are particularly rich in cis-acting
regulatory elements [55,56]. miRNAs can regulate their
target genes through the cis-acting regulatory elements
[57]. miRNAs within the same cluster might share the
same cis-regulatory elements [23], and therefore, might
have the same regulatory mechanism for their target
genes. Out of the 18 miRNA clusters identified in lungs
and 12 miRNA clusters identified in tracheae, there were
7 miRNA clusters differentially expressed in different
comparisons. The miRNAs from five of these clusters
(mir-16-1-mir-15a, mir-16-2-mir-15b, let-7f-let-7a-1, let-
7j-let-7k and mir-23b-mir-27b-mir-24) identified in both
lungs and tracheae were significantly down-regulated in
infected lungs compared to non-infected lungs and also
had higher expression levels in non-infected lungs than
non-infected tracheae. The mir-181a-1-mir181b-1 cluster
was significantly down-regulated in both infected lungs
and tracheae. And the mir-34b-mir-34c cluster was the
only significantly up-regulated cluster in the AIV infected
trachea. Different miRNA clusters had different regulation
direction in AIV infected tissues in the present study. This
illustrates that, during AIV infection, different modulation
mechanisms among different miRNA clusters might coex-
ist in both lungs and tracheae.
It is interesting to note that when considering the miRNA
clusters that were most active in chicken lung and trachea,
mir-17-92 cluster (consisting of six miRNAs) and mir-
302b-mir-302c-mir-1811-mir-302a-mir-302d-mir-367
cluster are highly associated with cell proliferation and
self-renewal of stem cells and cancer cells [58-61]. In addi-
tion the miRNAs clusters that were significantly down-reg-
ulated miR-15/16 and let-7 are typically down-regulated
in stem cells and cancer [62-64]. These results suggest that
Enriched immune related GO terms of target genes of induced differentially expressed miRNAs in comparison of non-infected lungs and tracheaeFigur  6
Enriched immune related GO terms of target genes of induced differentially expressed miRNAs in comparison 
of non-infected lungs and tracheae. Notes: Fold enrichment is a ratio obtained by dividing user's percentage by the per-
centage of each category of the whole genome.
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and self-renewal like behaviour in chicken lung epithe-
lium and the newly recruited T lymphocytes.
Modulation of target genes by miRNA is one of most crit-
ical steps for gene expression regulation. The targeted
genes for some differentially expressed miRNAs in the cur-
rent study were predicted using miRanda [24,65]. Interest-
ingly, many of the target genes were involved in the host
immune system. The potential target genes for miR-1a
and miR-1b are the T-cell immuno-modulatory protein.
MiR-34b and miR34c, whose target genes are B-cell CLL-
pymphoma 2 & 11, might be involved in the B-cell differ-
entiation. Target genes for miR-206 were associated with
monocyte macrophage differentiation, suggesting they
maybe associated with antigen presentation. Based on
other immune related miRNA studies in mammals
[11,66], differentially expressed miRNAs of their mamma-
lian homologs and their targets are presented in Table 9.
MiR-15a, miR-21 and miR-181a have important functions
in lymphocytes development and modulations while
miR-122 and miR-24 are related to virus infection and
miR-146a, induced by macrophages, can activate Toll like
receptor (TLR) and expose antigens to interleukin-1 beta.
Although the exact functions of these miRNAs in the AIV
infected chickens remains to be determined, candidate
miRNAs and their potential targets identified in the cur-
rent study provide strong evidence of their roles and war-
rant further investigation. Whether these chicken miRNAs
have the same function as mammals or not need to be val-
idated in the future studies. On-going efforts in the
author's laboratory focusing on gene expressions of these
target genes and determination of target genes for these
differentially expressed miRNAs will provide new insights
of miRNA regulations on AIV infection in chickens.
Conclusion
miRNAs have recently been implicated in the intricate
cross-talk between host and pathogen in viral infections
and are critical in viral pathogenesis. In AIV infected tis-
sues, expression patterns of some host miRNAs were sig-
nificantly differentially regulated in the current study,
supporting the hypothesis that certain miRNAs are essen-
tial in the host-pathogen interactions. Once the role of
these miRNAs in the regulation of host-AIV interaction
has been determined, it will improve the protective strat-
egies in AIV infection in poultry.
Methods
Sample collection and RNA isolation
One week old commercial Leghorn SPF chickens were
randomly divided into two groups (4 chickens per group),
housed in a negative pressure Horsfall-Bauer, temperature
control isolation unit, and provided with water and com-
mercial feed ad libitum. At three weeks of age, one group
was inoculated with 0.2 ml H5N3 virus containing 106.0
EID50/ml, while the other group was inoculated with PBS
by the intra-choanal cleft route. Based on the pilot study
at 4 dpi, depression and severely congested lungs and tra-
chea were observed. Therefore, all chickens were eutha-
nized at four days post-inoculation, and lung and trachea
epithelial layers were collected for RNA isolation. The ani-
mal experiment was performed according to the guide-
lines approved by the Institutional Animal Care and Use
Committee, Texas A&M University.
Two pools of total RNA samples (two random chickens
per pool) of each tissue from each group were generated.
Total RNAs were isolated using Trizol (Invitrogen,
Carlsbad, CA) following the manufacturer's protocol.
Dnase I (Ambion, Austin, TX) digestion was carried out
Table 9: miRNAs involvement in immune response [11]
miRNA Functions Targets
miR-15a Decreased expression in chronic lymphocytic leukaemia Bcl-2
miR-16 Binds to UA rich elements in 3' UTR and induces TNF alpha mRNA degradation TNFα
miR-21 Increased expression in B-cell lymphoma and chronic lymphocytic leukaemia
miR-17-5p Inhibits monocyte proliferation, differentiation and maturation AML-1
miR-20a Inhibits monocyte proliferation, differentiation and maturation AML-1
miR-106a Inhibits monocyte proliferation, differentiation and maturation AML-1
miR-24 Inhibits replication of vesicular stomatitis virus
miR-29a Down-regulated in B-cell chronic lymphocytic leukemia Tcl-1
miR-122 Required for hepatitis C proliferation in liver
miR-125b Expression downregulated by LPS and oscillations in expression after exposure to TNF alpha TNFα
miR-146a Expression induced in macropahges and epithilial following activation of TLR or exposure to TNF 
alpha and IL-1beta
IRAK1, TRAF6
miR-146b LPS induced expression induced in macrophages IRAK1, TRAF6
let-7i Regulates TLR-4 and contributes to cholangiocyte immune responses
miR-181a Positive regulator of B-cell development and CD4+ T-cell selection, activation and sensitivity SHP-2, PTPN22, DUSP5, DUSP6Page 16 of 20
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tions. The RNA concentration and purity were determined
by measuring absorbance at 260 nm and A260/A280 ratio
using a NanoDrop ND-1000 spectrophotometer (Nano-
drop Technologies, Wilmington, DE). RNA samples were
stored at -80°C until further use.
Viral Titration
Virus replication at 4 dpi was determined by real-time RT-
PCR for influenza matrix gene using AgPath-ID™ AIV- M
kit (Ambion, Austin, TX) following the manufacturer's
instructions. Control RNA was extracted from serially
diluted H5N3 virus (101.5-105.5 log10 EID50/ml). Standard
curve was generated with control viral RNAs. The amount
of RNA in the samples was converted into log10 EID50/ml
by interpolation as described previously [67].
Small RNA sequencing and analysis
For small RNA library construction, RNA samples were
prepared using the DGE-Small RNA Sample Prep Kit (Illu-
mina, San Diego, CA). In brief, RNA was purified by poly-
acrylamide gel electrophoresis (PAGE), to enrich for
molecules in the range of 18-30 nt, and ligated with pro-
prietary adapters to both 5' and 3' termini of the RNA.
Ligated samples were used as templates for cDNA synthe-
sis and then amplified with 15 PCR cycles to produce
sequencing libraries. A total of eight Solexa-ready small
RNA templates were prepared through two gel purifica-
tion steps to eliminate concatenated adaptors without
inserts. Purified cDNAs were quantified using the Quant-
iT PicoGreen dsDNA Kit (Invitrogen, Carlsbad, CA) and
diluted to 10 nM for sequencing on an Illumina 1G
Genome Analyzer at the Genome Sequencing Center of
Baylor College of Medicine. Cluster generation was per-
formed and clusters were sequenced.
For each sample, sequences were first passed through an
adaptor filter that searched for sequences that were fol-
lowed by at least 6 nucleotides of the 3' adaptor. Out of
the total reads, any reads without a perfect 10-nt linker
subsequence were directly discarded adjoining the insert,
yielding of length 10 nt or longer that were subject to fur-
ther processing. All full-length, exact sequence matches to
E. coli (k12, o157:h7, o157:h7 edl933, cft073) were dis-
carded to eliminate possible sequence artifacts arising
from the amplification process. All unique sequence reads
with a minimum read count of 10 were aligned with pre-
cursor chicken miRNA sequences from miRBase version
13.0 [19-22]. Reads of each miRNA were the sum of exact
and loose matches (± 4 bp) to known miRNAs. For each
sample, counts were normalized to the total number of
small RNA sequences, and then for each miRNA, the nor-
malized number of counts was compared between groups
or between tissues.
Fisher's Exact test was used to identify differentially
expressed miRNAs at a 5% false discovery rate. False dis-
covery rate (FDR) (Q values) was calculated by R program
according to Benjamin and Hochberg's method [68].
Ratios were calculated as the ratio of normalized reads of
infected over non-infected group or lung over trachea. Sta-
tistics related to over representation of functional catego-
ries were performed using DAVID, which is based upon a
Fisher Exact statistic methodology similar to that
described by Al-Shahrour et al [69]. A P < 0.05 was consid-
ered as significant.
Novel miRNAs from both lung and trachea libraries were
identified using the method by Creighton et al. 2009 [70].
In brief, the first step is to take the sequence reads that did
not map to known miRNA precursors, mapped them to
the chicken genome, and got an exact sequence match
along with 100 bases flanking either side. About 220-bp
sequence was then tested for miRNA-like hairpin struc-
ture, and folded with the Vienna package [71]. The
miRNA hairpin structures that meet the Ambros [22] cri-
teria were identified. Specifically, the putative miRNA
must lie on one arm of a single-loop hairpin with mini-
mum free energy less than -25 kcal/mol. The sequence
reads that were appropriately placed in these miRNA-like
hairpins were considered as 'putative mature miRNAs'
(pmms). Then we examined the pmms for cross-species
conservation of the hairpin structure. The sequence reads
with strong conservation of the mature miRNA, signifi-
cant conservation of the hairpin arm opposite the mature
miRNA, and little or no conservation of the hairpin loops
were considered as novel miRNAs.
Confirmation of novel miRNAs by miScript real-time 
quantitative RT-PCR
Novel potential miRNA expression was determined by
using the same total RNA samples for small RNA library
constructions. Total RNA (1 μg) was reverse-transcribed
with miScript Reverse Transcription Kit from QIAGEN
(Valencia, CA). The real-time quantification of a selected
subset of novel miRNAs (C1N1: AAGCUGCCAGUUGAA-
GAACU; C1N2: AAGGUCCAACCUCACAUGUCC; C1N3:
UUGGUGGUUCAGUGGUAGAA; C1N4: AGAAUUGCG-
UUUGGACAAUC; C1N5: CACAAGAAUUGCGUUUG-
GACAA; C1N6: UUGACAUCAUCAUACUUGGGAU and
C1N7: UGGCAGUGCGUGUUAGCUGGCUGUU) was
carried out with customer designed miScript Primer
Assays and miScript SYBR Green PCR Kit from QIAGEN
(Valencia, CA). Chicken small nuclear RNA U6 (GCAG-
GGGCCAUGCUAAUCUUCUCUGUAUCG) was used for
normalization. The expression levels of novel miRNAs
were measured in terms of threshold cycle value (CT) and
normalized to U6 using 2-ΔΔCT [72].Page 17 of 20
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TaqMan MicroRNA Assay
To determine the expression of miRNAs by quantitative
RT-PCR (qRT-PCR), TaqMan microRNA assay was per-
formed. The specific stem-loop RT primers of miR-1a,
miR125b, miR-146a and U6 were obtained commercially
from Applied Biosystems (Foster City, Calif., USA). In
brief, cDNA was synthesized from total RNA by using the
gene specific primers according to the protocol of TaqMan
Micro RNA Assays (Applied Biosystems, CA, USA).
Reverse transcriptase reactions contained 10 ng of RNA
samples, 3 μl stem loop RT primer and reagents from a
TaqMan MicroRNA Reverse Transcription Kit (Applied
Biosystems, CA, USA). The 15 μl reactions were incubated
for 30 min at 16°C, 30 min at 42°C and 5 min at 85°C,
and then held at 4°C.
Real-time PCR was performed by using gene specific
probes and a pair of primers (TaqMan MicroRNA Assays,
Applied Biosystems) and reagents of TaqMan 2* Univer-
sal PCR Master Mix (No AmpErase UNG) (Applied Bio-
systems, CA, USA). The 20 μl PCR reactions included 1.33
μl RT-PCR product, 10 μl PCR master mix, and 1 μl 20*
TaqMan MicroRNA Assay mix (Applied Biosystems, CA,
USA). These reactions were incubated at 95°C for 10 min,
followed by 40 cycles at 95°C for 10 s, 60°C for 40 s and
72°C for 1 s by ABI 7900 Realtime PCR instrument
(Applied Biosystems, CA, USA). All reactions were run in
triplicates. The threshold cycle was defined as the frac-
tional cycle number at which the fluorescence passes the
fixed threshold. The expression levels of miR-1a, miR-
125b and miR-146a in each sample were measured in
terms of threshold cycle value and normalized to U6 using
2-ΔΔCT [72]. U6 was used as an internal control.
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